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Abstract  There is concern regarding the possible
health effects of cellular telephone use. We con-
ducted a systematic review of studies of controlled
exposure to radiofrequency radiation with health-
related outcomes (electroencephalogram, cognitive
or cardiovascular function, hormone levels, symp-
toms, and subjective well-being). We searched
Embase, Medline, and a specialist database in Feb-
ruary 2005 and scrutinized reference lists from rel-
evant publications. Data on the source of funding,
study design, methodologic quality, and other study
characteristics were extracted. The primary out-
come was the reporting of at least one statistically
significant association between the exposure and
a health-related outcome. Data were analyzed us-
ing logistic regression models.  Of 59 studies, 12
(20%) were funded exclusively by the telecommu-
nications industry, 11 (19%) were funded by pub-
lic agencies or charities, 14 (24%) had mixed fund-
ing (including industry), and in 22 (37%) the
source of funding was not reported. Studies funded
exclusively by industry reported the largest num-
ber of outcomes, but were least likely to report a
statistically significant result. The interpretation
of results from studies of health effects of radiofre-
quency radiation should take sponsorship into
account.
Key words  Electromagnetic fields, Financial con-
flicts of interest, Human laboratory studies, Mo-
bile phones
Resumo  Foi realizada uma revisão sistemática
de estudos de exposição controlada à radiação de
radiofreqüência com resultados relacionados à
saúde (eletroencefalograma, função cognitiva ou
cardiovascular, níveis hormonais, sintomas e
bem-estar subjetivo). Foram pesquisados o Em-
base, Medline e um banco de dados especializado
e analisadas listas de referências de publicações
relevantes. Foram extraídos dados sobre a fonte
de financiamento, desenho do estudo, qualidade
metodológica e outras características do estudo.
A principal descoberta foi o relato de pelo menos
uma associação estatisticamente significativa
entre a exposição e um resultado relacionado à
saúde. Os dados foram analisados usando-se mod-
elos de regressão logística. De 59 estudos, 12 (20%)
foram financiados exclusivamente pela indústria
de telecomunicação, 11 (19%), por órgãos públi-
cos ou de caridade, 14 (24%) tiveram financia-
mentos combinados (inclusive da indústria) e em
22 (37%) a fonte de financiamento não foi noti-
ficada. Os estudos financiados exclusivamente pela
indústria tiveram o maior número de resultados,
mas menos propensão a relatar um resultado sig-
nificativo. A interpretação dos resultados dos es-
tudos sobre os efeitos da radiação de radiofreqüên-
cia à saúde deve levar em conta o patrocínio.
Palavras-chave  Campos eletromagnéticos, Con-
flitos de interesse financeiro, Estudos laborato-
riais, Telefones celulares
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The use of mobile telephones has increased rap-
idly in recent years. The emission of low level
radiofrequency electromagnetic fields leading to
the absorption of radiation by the brain in users
of handheld mobile phones has raised concerns
regarding potential effects on health1. However,
the studies examining this issue have produced
conflicting results, and there is ongoing debate
on this issue2,3. Many of the relevant studies have
been funded by the telecommunications indus-
try, and thus may have resulted in conflicts of
interest4. Recent systematic reviews of the influ-
ence of financial interests in medical research con-
cluded that there is a strong association between
industry sponsorship and pro-industry conclu-
sions5,6. This association has not been examined
in the context of the studies of potential adverse
effects of mobile phone use. We performed a sys-
tematic review and analysis of the literature to
examine whether industry involvement is associ-
ated with the results and methodologic quality
of studies.
Methods
We searched Embase (http://www.embase.com)
and Medline http://www.ncbi.nlm.nih.gov/en-
trez/query.fcgi?DB=pubmed) in February 2005.
Key and free text words included “cell(ular),”
“mobile,” “(tele)phone(s)” in connection with
“attention,” “auditory,” “bioelectric,” “brain phys-
iology,” “cardiovascular,” “cerebral,” “circulatory,”
“cognitive,” “EEG,” “health complaint(s),” “hear-
ing,” “heart rate,” “hormone(s),” “learning,” “me-
latonin,” “memory,” “neural,” “neurological,”
“nervous system,” “reaction,” “visual,”
“symptom(s),” or “well-being.” The search was
complemented with references from a specialist
database7 and by scrutinizing reference lists from
the relevant publications. Articles published in
English, German, or French were considered.
We included original articles that reported
studies of the effect of controlled exposure with
radiofrequency radiation on health related out-
comes [“human laboratory studies” in World
Health Organization (WHO) terminology8].
Health-related outcomes included electroenceph-
alogram (EEG) recordings, assessments of cog-
nitive or cardiovascular function, hormone lev-
els, and subjective well-being and symptoms. We
excluded studies of the risk of using mobile phones
when driving a motor vehicle or operating ma-
chinery as well as studies on electromagnetic field
(EMF) incompatibilities (e.g. pacemakers or hear-
ing aids). Three of us (AH, KH, MR) indepen-
dently extracted data on the source of funding
(industry, public or charity, mixed, not reported)
and potential confounding factors, including study
design (crossover, parallel, other), exposure (fre-
quency band, duration, field intensity, and loca-
tion of antenna), and methodologic and report-
ing quality. Four dimensions of quality were as-
sessed8,9: a) randomized, concealed allocation of
study participants in parallel or crossover trials;
b) blinding of participants and investigators to
allocation group; c) reporting of the specific ab-
sorption rate (SAR; watts per kilogram tissue)
from direct measurement using a phantom head
or three-dimensional dosimetric calculations (“ap-
propriate exposure setting”); d) appropriate sta-
tistical analysis. For each item, studies were classi-
fied as adequate or inadequate/unclear.
The primary outcome was the reporting of at
least one statistically significant (p < 0.05) associ-
ation between radiofrequency exposure and a
health-related outcome. The message in the title
was also assessed. We distinguished among neu-
tral titles [e.g., “Human brain activity during ex-
posure to radiofrequency fields emitted by cellu-
lar phones”10], titles indicating an effect of radia-
tion [e.g., “Exposure to pulsed high-frequency
electromagnetic field during waking affects hu-
man sleep EEG”11], and titles stating that no ef-
fect was shown [e.g., “No effect on cognitive func-
tion from daily mobile phone use”12]. Finally,
authors’ declaration of conflicts of interest
(present, absent) and affiliations (industry, oth-
er) were recorded.
Differences in data extracted by AH, KH, and
MR were resolved in the group, with the senior
epidemiologist (MR) acting as the arbiter. In ad-
dition, two of us (KHM, ME), who were kept
blind to funding source, authors, and institu-
tions, repeated extraction of data from abstracts
and assessments of titles. Differences in data ex-
tracted by KHM and ME were resolved with the
senior epidemiologist (ME) acting as the arbiter.
Based on the abstracts, we assessed whether au-
thors interpreted their study results as showing
an effect of low-level radiofrequency radiation,
as showing no effect, or as indicating an unclear
finding. We used logistic regression models to
assess whether the source of funding was associ-
ated with the reporting of at least one significant
effect in the article (including the abstract). We
examined the influence of potential confound-
ers, such as the total number of outcomes that
were reported in the article, the type of study
(crossover, parallel, other), the four dimensions
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of study quality (adequate or not adequate/un-
clear), exposure conditions (position of the an-
tenna next to the ear compared with other loca-
tions; use of the 900-MHz band compared with
other bands; duration of exposure in minutes),
as well as the type of outcome (e.g., cognitive
function tests: yes vs. no). Variables were entered
one at a time and, given the limited number of
studies, models were adjusted for one variable
only. Results are reported as odds ratios (ORs)
with 95% confidence intervals (CIs). All analyses
were carried out in Stata (version 8.2; StataCorp.,
College Station, TX, USA).
Results
We identified 222 potentially relevant publications
and excluded 163 studies that did not meet inclu-
sion criteria (Figure 1). We excluded one study
Figure 1. Identification of eligible studies.
Potentially eligible articles identified
(n = 222)
59 studies included in analyses
Exclusions based on title or abstract
(n = 142)
. Studies of the risk of using mobile phones when driving
a motor vehicle or operating machinery
(n = 29)
. Studies of the use of mobile phones in the monitoring
of and communication with patients
(n = 28)
. Other study designs
(n = 29)
. Studies of interference with hearing aids or pacemakers
(n = 28)
. Studies of other exposures or methodologic issues
(n = 26)
. Animal studies
(n = 2)
Excluded
(n = 21)
. Other study design
(n = 9)
. Published in Chinese or Russian
(n = 3)
. Publication was withdrawn
(n = 1)
. Double publications
(n = 5)
. Studies of reducing exposure (“shielding studies”)
(n = 2)
. Funded by company producing “shielding devices”
(n = 1)
80 full-text articles examined
?
?
?
?
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that had been funded by a company producing
“shielding” devices that reduce EMF exposure13.
A total of 59 studies were included: 12 (20%) were
exclusively funded by the telecommunications
industry, 11 (19%) were funded by public agen-
cies or charities, 14 (24%) had mixed funding
(including industry and industry-independent
sources), and in 22 (37%) studies the source of
funding was not reported. None of 31 journals
published a statement on possible conflicts of
interest of the 287 authors listed in the bylines.
Five (8%) studies had authors with industry af-
filiation. All studies except two (3%) were pub-
lished in journals that use peer review, and one
was published in a journal supplement. The bib-
liographic references are given in the Supplemen-
tal Material (http://www.ehponline.org/members/
2006/9149/supplemental.pdf). Blinded and open
extraction of data yielded identical results with
respect to the reporting of statistically significant
effects in the abstract and the message of the title.
Study characteristics are shown in Table 1.
All studies were published during 1995-2005,
with the number of publications increasing from
one to two publications per year to 11 publica-
tions in 2004. Median year of publication was 1998
for industry-funded studies, 2002 for public or
charity funding and studies with mixed funding
sources, and 2003 for studies that did not report
their funding source. The median size of all the
studies was small (20 study participants); most
studies (n = 32, 54%) were of a crossover design
Table 1. Characteristics of 59 experimental studies of the effects of exposure to low-level radiofrequency
electromagnetic fields.
Study characteristic
Study design [nº (%)]
Crossover trial
Parallel group trial
Other, unclear
Exposure [nº (%)]
Location of antenna
Next to ear
Other/unclear
Frequency band a
900 MHZ
Other frequencies
Unclear
Median duration of exposure (range)
Outcome assessed [nº (%)]a
Eletroencephalogram
Cognitive function tests
Hormone levels
Cardiovascular function
Cardiovascular function
Well-being or symptoms
Other
Study quality [nº (%)]a
Randomization adequate
Participants and assessors blinded
SAR determined
Statistical analysis adequate
Median study size [range]
Source of funding
Industry
(n = 12)
10 (83.3)
0 (0)
2 (16.7)
4 (33.3)
8 (66.7)
11 (91.7)
2 (16.7)
0 (0)
180 (3-480)
7 (58.3)
0 (0)
5 (41.7)
2 (16.7)
1 (8.3)
4 (33.3)
10 (83.3)
1 (8.3)
4 (33.3)
3 (25)
21 (8-39)
Public or charity
(n = 11)
7 (63.6)
2 (18.2)
2 (18.2)
8 (72.7)
3 (27.3)
8 (72.7)
7 (63.6)
0 (0)
20 (5-35)
5 (45.5)
3 (27.3)
0 (0)
1 (9.1)
1 (9.1)
3 (27.3)
7 (63.6)
3 (27.3)
4 (36.4)
3 (27.3)
24 (13-100)
Mixed
(n = 14)
12 (85.7)
1 (7.1)
1 (7.1)
11 (78.6)
3 (21.4)
13 (92.9)
0 (0)
1 (7.1)
45 (30-240)
8 (57.1)
8 (57.1)
0 (0)
0 (0)
1 (7.1)
1 (7.1)
13 (92.9)
8 (57.1)
8 (57.1)
7 (50)
20 (13-96)
Not reported
(n = 22)
11 (50)
2 (9.1)
9 (40.9)
14 (63.6)
8 (36.4)
14 (63.6)
5 (22.7)
5 (22.7)
30 (4-480)
12 (54.5)
8 (36.4)
2 (9.1)
2 (9.1)
0 (0)
3 (13.6)
9 (40.9)
3 (13.6)
2 (9.1)
1 (4.5)
20 (8-78)
Percentages are column percentages.
a The same study could be listed in more than one category.
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and mimicked the exposure situation during a
phone call, using the 900-MHz band with the an-
tenna located close to the ear. Exposure duration
ranged from 3 to 480 min, with a median of 33
minutes. Thirty-three (59%) studies measured
outcomes during exposure, 14 (24%) postexpo-
sure, and 12 (20%) at both times. Thirty-nine
(66%) studies prevented selection bias with ade-
quate randomization; 15 (25%) blinded both par-
ticipants and assessors; in 18 (31%) the field in-
tensity had been assessed appropriately, with SAR
values ranging from 0.03 to 2 W/kg tissue. Finally,
in 14 (24%) studies we considered the statistical
analysis to be adequate. Study quality varied by
source of funding: Studies with mixed funding (in-
cluding public agencies or charities and industry)
had the highest quality, whereas studies with no
reported source of funding did worst (Table 1).
Forty (68%) studies reported one or more
statistically significant results (p < 0.05) indicat-
ing an effect of the exposure (Table 2). Studies
funded exclusively by industry reported on the
largest number of outcomes but were less likely
to report statistically significant results: The OR
for reporting at least one such result was 0.11
(95% CI, 0.02–0.78), compared with studies fund-
ed by public agencies or charities (Table 3). This
finding was not materially altered in analyses
adjusted for the number of outcomes reported,
study design and quality, exposure characteris-
tics, or outcomes [Table 3; see Supplemental
Material, Table 1 (http://www.ehponline.org/
members/2006/9149/supplemental.pdf)]. Similar
results were obtained when restricting analyses
to results reported in abstracts (OR = 0.29; 95%
CI, 0.05-1.59) or on the conclusions in the ab-
stract (OR = 0.10, 95% CI, 0.009-1.10). Thirty-
seven (63%) studies had a neutral title, 11 (19%)
a title reporting an effect, and 11 (19%) a title
reporting no effect (Table 2).
Percentages are column percentages.
a Two publications that did not report their source of funding had no abstracts.
Table 2. Results from assessments of article text, abstract, and title of 59 experimental studies of the
effects of exposure to low-level radiofrequency electromagnetic fields.
Article text
Nº (%) studies with at least one result
suggesting an effect at p < 0.05
Median nº (range) of outcomes reported
Median nº (range) of outcomes
suggesting an effect at p < 0.05
Abstract a
Nº (%) studies with at least one result
suggesting a significant effect
Median nº (range) of outcomes reported
Median nº (range) of outcomes
suggesting a significant effect
Authors’ interpretation of results [nº (%)]
No effect of radiofrequency radiation
Effect of radiofraquency radiation
Unclear finding
Title [nº (%)]
Neutral
Statement of effect
Statement of no effect
Source of funding
Industry
(n = 12)
4 (33)
17.5 (4-31)
0 (0-6)
(n = 12)
4 (33)
3.5 (1-36)
0 (0-6)
10 (83.3)
1 (8.3)
1 (8.3)
7 (58)
0 (0)
5 (42)
Public or charity
(n = 11)
9 (82)
10 (1-80)
1.5 (0-7)
(n = 11)
7 (6)
3 (1-5)
1 (0-3)
5 (45.5)
5 (45.5)
1 (9)
5 (46)
4 (36)
2 (18)
Mixed
(n = 14)
10 (71)
16 (9-44)
3 (0-15)
(n = 14)
10 (71)
6.5 (3-44)
2 (0-5)
4 (28.6)
8 (57.1)
2 (14.3)
8 (57)
3 (21)
3 (21)
Not reported
(n = 22)
17 (77)
7 (3-35)
1.5 (0-12)
(n = 20)
15 (5)
3 (1-64)
1.5 (0-7)
5 (22.7)
14 (63.6)
13 (13.6)
17 (77)
4 (18)
1 (5)
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Discussion
We examined the methodologic quality and re-
sults of experimental studies investigating the ef-
fects of the type of radiofrequency radiation emit-
ted by handheld cellular telephones. We hypothe-
sized that studies would be less likely to show an
effect of the exposure if funded by the telecom-
munications industry, which has a vested interest
in portraying the use of mobile phones as safe.
We found that the studies funded exclusively by
industry were indeed substantially less likely to
report statistically significant effects on a range of
end points that may be relevant to health. Our
findings add to the existing evidence that single-
source sponsorship is associated with outcomes
that favor the sponsors’ products5,14-16. Most pre-
vious studies of this issue were based on studies
of the efficacy and cost-effectiveness of drug treat-
ments. A recent systematic review and meta-anal-
ysis showed that studies sponsored by the phar-
maceutical industry were approximately four
times more likely to have outcomes favoring the
sponsor’s drug than studies with other sources of
funding15. The influence of the tobacco industry
on the research it funded has also been investigat-
ed17-19. To our knowledge, this is the first study to
examine this issue in the context of exposure to
radiofrequency electromagnetic fields. Our study
has several limitations. We restricted our analysis
to human laboratory studies. This resulted in a
more homogenous set of studies, but may have
reduced the statistical power to demonstrate or
exclude smaller associations. The WHO has iden-
tified the need for further studies of this type to
clarify the effects of radiofrequency exposure on
neuroendocrine, neurologic, and immune sys-
tems20. We considered including epidemiologic
studies but found that practically all of them were
publicly funded. The study’s primary outcome -
the reporting of statistically significant associa-
tions - is a crude measure that ignores the size of
reported effects. However, we found the same
trends when assessing the authors’ conclusions in
the abstracts. Although we have shown an associ-
ation between sponsorship and results, it remains
unclear which type of funding leads to the most
accurate estimates of the effects of radiofrequen-
cy radiation. For example, if researchers with an
environmentalist agenda are more likely to be
funded by public agencies or charities, then their
bias may result in an overestimation of effects.
Interestingly, studies with mixed funding were of
the highest quality. The National Radiological Pro-
tection Board21 reviewed studies of health effects
from radiofrequency (RF) fields and concluded
that scientific evidence regarding effects of RF field
exposure from mobile phones on human brain ac-
Table 3. Probability of reporting at least one statistically significant result (p < 0.05) according to source of
funding: crude and adjusted ORs (95% CIs) from logistic regression models.
Crude
Adjusted for
Nº of reported outcomes
Median study size
Study design (crossover, parallel,
or other)
Study quality
Randomization adequate
Participants and assessors blinded
Statistical analysis adequate
Exposure setting appropriate
Source of funding
Industry
(n = 12)
0.11 (0.02-0.78)
0.12 (0.02-0.89)
0.08 (0.009-0.62)
0.08 (0.014-0.68)
0.04 (0-0.56)
0.14 (0.02-0.96)
0.12 (0.02-0.85)
0.13 (0.02-0.89)
Public or
charity
(n = 11)
1 (reference)
1 (reference)
1 (reference)
1 (reference)
1 (reference)
1 (reference)
1 (reference)
1 (reference)
Mixed
(n = 14)
0.56 (0.08-3.80)
0.60 (0.08-4.28)
0.61 (0.08-4.59)
0.38 (0.05-3.07)
0.16 (0.01-2.15)
0.54 (0.08-3.91)
0.67 (0.09-4.85)
0.47 (0.07-5.5)
Not reported
(n = 22)
0.76 (0.12-4.70)
0.96(0.15-6.23)
0.57 (0.08-4.02)
1.16 (0.16-8.61)
1.27 (0.16-9.89)
0.76 (0.12-4.8)
0.54 (0.08-3.76)
0.86 (0.14-5.5)
p-Valuea
0.04
0.04
0.02
0.029
0.005
0.09
0.07
0.06
Models adjusted for one variable at a time.
a From likelihood ratio tests.
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tivity and cognitive function […] has included re-
sults both supporting and against the hypothesis of
an effect. We found that the source of funding
explains some of the heterogeneity in the results
from different studies. The association was ro-
bust and little affected by potential confounding
factors such as sample size, study design, or qual-
ity. Possible explanations for the association be-
tween source of funding and results have been
discussed in the context of clinical research spon-
sored by the pharmaceutical industry5,15, 22. The
association could reflect the selective publication
of studies that produced results that fitted the
sponsor’s agenda. Sponsors might influence the
design of the study, the nature of the exposure,
and the type of outcomes assessed. In multivari-
ate logistic regression analysis, the only factor that
strongly predicted the reporting of statistically sig-
nificant effects was whether or not the study was
funded exclusively by industry. We stress that our
ability to control for potential confounding fac-
tors may have been hampered by the incomplete
reporting of relevant study characteristics.  Med-
ical and science journals are implementing poli-
cies that require authors to disclose their financial
and other conflicts of interest. None of the articles
examined here included such a statement, in line
with a survey of science and medical journals that
showed that adopting such policies does not gen-
erally lead to the publication of disclosure state-
ments23. A review of 2005 instructions to authors
showed that 15 (48%) of the 31 journals included
in our study had conflict of interest policies. Our
results support the notion that disclosure state-
ments should be published, including statements
indicating the absence of conflicts of interest. The
role of the funding source in the design, conduct,
analysis, and reporting of the study should also
be addressed. There is widespread concern regard-
ing the possible health effects associated with the
use of cellular phones, mobile telephone base sta-
tions, or broadcasting transmitters. Most (68%)
of the studies assessed here reported biologic ef-
fects. At present it is unclear whether these biolog-
ic effects translate into relevant health hazards.
Reports from national and international bodies
have recently concluded that further research ef-
forts are needed, and dedicated research programs
have been set up in the United States, Germany,
Denmark, Hungary, Switzerland, and Japan. Our
study indicates that the interpretation of the re-
sults from existing and future studies of the health
effects of radiofrequency radiation should take
sponsorship into account.
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